These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8050453)

  • 1. Systemic lupus erythematosus is associated with increased auto-antibody titers against calreticulin and grp94, but calreticulin is not the Ro/SS-A antigen.
    Boehm J; Orth T; Van Nguyen P; Söling HD
    Eur J Clin Invest; 1994 Apr; 24(4):248-57. PubMed ID: 8050453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-calreticulin segregates anti-Ro sera in systemic lupus erythematosus: anti-calreticulin is present in sera with anti-Ro alone but not in anti-Ro sera with anti-La or anti-ribonucleoprotein.
    Scofield RH; Racila DM; Gordon TP; Kurien BT; Sontheimer RD
    J Rheumatol; 2000 Jan; 27(1):128-34. PubMed ID: 10648028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a calreticulin-binding nuclear protein as histone (H1), an autoantigen in systemic lupus erythematosus.
    Treves S; Bajocchi G; Zorzato F; Govoni M; Trotta F
    Lupus; 1998; 7(7):479-87. PubMed ID: 9796851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine specificity of autoantibodies to calreticulin: epitope mapping and characterization.
    Eggleton P; Ward FJ; Johnson S; Khamashta MA; Hughes GR; Hajela VA; Michalak M; Corbett EF; Staines NA; Reid KB
    Clin Exp Immunol; 2000 May; 120(2):384-91. PubMed ID: 10792392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions.
    Zappi E; Sontheimer R
    Immunol Invest; 1993 Apr; 22(3):189-203. PubMed ID: 8509157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of calreticulin in systemic lupus erythematosus.
    Eggleton P; Reid KB; Kishore U; Sontheimer RD
    Lupus; 1997; 6(7):564-71. PubMed ID: 9302659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calreticulin synthetic peptide analogues: anti-peptide antibodies in autoimmune rheumatic diseases.
    Routsias JG; Tzioufas AG; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
    Clin Exp Immunol; 1993 Mar; 91(3):437-41. PubMed ID: 7680295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological cross-reactivity between a human Ro/SS-A autoantigen (calreticulin) and the lambda Ral-1 antigen of Onchocerca volvulus.
    Lux FA; McCauliffe DP; Büttner DW; Lucius R; Capra JD; Sontheimer RD; Lieu TS
    J Clin Invest; 1992 Jun; 89(6):1945-51. PubMed ID: 1602002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SS-56, a novel cellular target of autoantibody responses in Sjögren syndrome and systemic lupus erythematosus.
    Billaut-Mulot O; Cocude C; Kolesnitchenko V; Truong MJ; Chan EK; Hachula E; de la Tribonnière X; Capron A; Bahr GM
    J Clin Invest; 2001 Sep; 108(6):861-9. PubMed ID: 11560955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE).
    van den Berg RH; Siegert CE; Faber-Krol MC; Huizinga TW; van Es LA; Daha MR
    Clin Exp Immunol; 1998 Feb; 111(2):359-64. PubMed ID: 9486404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti-Ro60 kD autoantibodies.
    Staikou EV; Routsias JG; Makri AA; Terzoglou A; Sakarellos-Daitsiotis M; Sakarellos C; Panayotou G; Moutsopoulos HM; Tzioufas AG
    Clin Exp Immunol; 2003 Oct; 134(1):143-50. PubMed ID: 12974767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete congenital heart block is associated with increased autoantibody titers against calreticulin.
    Orth T; Dorner T; Meyer Zum Buschenfelde KH; Mayet WJ
    Eur J Clin Invest; 1996 Mar; 26(3):205-15. PubMed ID: 8904349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can B cell epitopes of 60 kDa Ro distinguish systemic lupus erythematosus from Sjögren's syndrome?
    Scofield AN; Kurien BT; Gordon TP; Scofield RH
    Lupus; 2001; 10(8):547-53. PubMed ID: 11530996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the autoantigen calreticulin.
    Rokeach LA; Haselby JA; Meilof JF; Smeenk RJ; Unnasch TR; Greene BM; Hoch SO
    J Immunol; 1991 Nov; 147(9):3031-9. PubMed ID: 1919005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular chaperones are targets of autoimmunity in Ro(SS-A) immune mice.
    Kinoshita G; Purcell AW; Keech CL; Farris AD; McCluskey J; Gordon TP
    Clin Exp Immunol; 1999 Feb; 115(2):268-74. PubMed ID: 9933452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological roles of calreticulin in autoimmune disease.
    Eggleton P; Llewellyn DH
    Scand J Immunol; 1999 May; 49(5):466-73. PubMed ID: 10320638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher incidences of anti-SS-A/Ro and anti-SS-B/La autoantibodies in Japanese patients with autoimmune disorders--studies of antigens and antibodies using the immunoblotting method.
    Inagaki Y; Jinno Y; Hamasaki Y; Ueki H
    Arch Dermatol Res; 1989; 281(2):89-94. PubMed ID: 2774641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibody responses to the "native" 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren's syndrome.
    Buyon JP; Slade SG; Reveille JD; Hamel JC; Chan EK
    J Immunol; 1994 Apr; 152(7):3675-84. PubMed ID: 7511655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1q inhibits autoantibody binding to calreticulin.
    Racila DM; Sontheimer RD
    Lupus; 1999; 8(4):300-4. PubMed ID: 10413209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of anti-La(SS-B) is associated with binding to the 13-kD carboxyl terminus of 60-kD Ro(SS-A) in systemic lupus erythematosus.
    Dickey WD; van Egmond JE; Hardgrave KL; Harley JB; Scofield RH
    J Invest Dermatol; 1993 Apr; 100(4):412-6. PubMed ID: 8454905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.